MKC vs TOVX · P/E 8.4, rev $3.81B vs rev $300.0K
McCormick & Company Incorporated (MKC) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
MKC currently screens at market cap $13.56B and trailing P/E 8.4. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the MKC and TOVX stock pages for the full models.
Not investment advice.